Wordt geladen...
Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier
Monoclonal antibodies (mAbs) are used with increasing success against many tumors, but for brain tumors the blood-brain barrier (BBB) is a special concern. The BBB prevents antibody entry to the normal brain; however, its role in brain tumor therapy is more complex. The BBB is closest to normal at m...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Landes Bioscience
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3092616/ https://ncbi.nlm.nih.gov/pubmed/21150307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.3.2.14239 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|